Susquehanna International Group’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Buy |
29,197
+9,288
| +47% | +$103K | ﹤0.01% | 4932 |
|
|
2025
Q1 | $245K | Buy |
19,909
+7,295
| +58% | +$89.7K | ﹤0.01% | 5286 |
|
|
2024
Q4 | $141K | Buy |
+12,614
| New | +$141K | ﹤0.01% | 5514 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6233 |
|
|
2024
Q2 | – | Sell |
-203,776
| Closed | -$2.69M | – | 6288 |
|
|
2024
Q1 | $2.69M | Buy |
203,776
+161,491
| +382% | +$2.13M | ﹤0.01% | 1509 |
|
|
2023
Q4 | $436K | Buy |
+42,285
| New | +$436K | ﹤0.01% | 4050 |
|
|
2023
Q2 | – | Sell |
-14,052
| Closed | -$65.2K | – | 6217 |
|
|
2023
Q1 | $65.2K | Buy |
+14,052
| New | +$65.2K | ﹤0.01% | 5379 |
|